Status:
COMPLETED
Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes
Lead Sponsor:
Acorda Therapeutics
Conditions:
Idiopathic Parkinson's Disease
Eligibility:
All Genders
30-85 years
Phase:
PHASE3
Brief Summary
This randomized, multicenter, placebo-controlled, double-blind study will evaluate the efficacy and safety of inhaled CVT 301 compared with placebo in PD patients experiencing motor response fluctuati...
Eligibility Criteria
Inclusion
- Idiopathic Parkinson's Disease (PD) diagnosed between the ages of 30 and 85 years;
- Hoehn and Yahr Stage 1-3 in an "on" state;
- Require levodopa-containing medication regimen at least 3 times during the waking day;
- Experience motor fluctuations with a minimum of 2 hours of average daily "off" time per waking day (excluding early morning "off" time) and demonstrate levodopa responsiveness;
- Are on stable PD medication regimen;
- Total daily LD dose \<1600 mg/day;
- Able to perform a spirometry maneuver in the ON and OFF states;
- Normal cognition confirmed by MMSE score ≥25
Exclusion
- Pregnant or lactating females;
- Previous surgery for PD or plan to have stereotactic surgery during the study period;
- History of psychotic symptoms requiring treatment, or suicide ideation or attempt within last year;
- Known contraindication to the use of levodopa;
- Any significant condition, severe concurrent disease, abnormality or finding that would make patients unsuitable or may compromise patient safety;
- Any contraindication to performing routine spirometry.
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
351 Patients enrolled
Trial Details
Trial ID
NCT02240030
Start Date
November 1 2014
End Date
December 1 2016
Last Update
May 28 2019
Active Locations (74)
Enter a location and click search to find clinical trials sorted by distance.
1
Acorda Site #5020
Scottsdale, Arizona, United States, 85259
2
Acorda Site #5042
Fresno, California, United States, 93710
3
Acorda Site #5064
Fullerton, California, United States, 92835
4
Acorda Site #5035
Loma Linda, California, United States, 92354